Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Coagulation01:09

Coagulation

6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of chromatin remodeling and immunopharmacology in cancer therapy.

Molecular medicine (Cambridge, Mass.)·2026
Same author

First identification and molecular characterisation of a rare D- - donor in Saudi Arabia.

Transfusion medicine (Oxford, England)·2026
Same author

Erythroferrone in β-thalassemia: Systematic review and meta-analysis.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

An Overview of Transfusion-Transmitted Infectious Agents among Blood Donors in Saudi Arabia.

Clinical laboratory·2026
Same author

Impact of smoked and smokeless tobacco on oral epithelium: A comparative study in Jazan region.

Tissue & cell·2026
Same author

Association Between Genotype and Plasma Levels of EPCR in Type 2 Diabetes Mellitus in Jazan Region, Saudi Arabia: A Case-Control Study.

International journal of general medicine·2026

Related Experiment Video

Updated: Jul 6, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K

Exploring antithrombin: insights into its physiological features, clinical implications and analytical techniques.

Muhammad Saboor1, Hassan A Hamali2, Abdullah A Mobarki2

  • 1Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|January 5, 2024
PubMed
Summary

Antithrombin, a key anticoagulant protein, regulates blood clotting and possesses anti-inflammatory, antitumor, and antiviral properties. This review updates on its structure, functions, deficiencies, and detection methods.

More Related Videos

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

988
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Related Experiment Videos

Last Updated: Jul 6, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

988
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Antithrombin is a vital serine protease inhibitor synthesized in the liver, crucial for regulating coagulation.
  • It comprises 432 amino acids, featuring distinct domains for heparin and serine protease binding.
  • Antithrombin contributes significantly to plasma anticoagulant activity and offers anti-inflammatory, antitumor, and antiviral benefits.

Approach:

  • This review synthesizes current knowledge on antithrombin.
  • It details the protein's structure, including its three functional domains.
  • The review covers antithrombin's diverse physiological functions and clinical relevance.

Key Points:

  • Antithrombin deficiency can be inherited (Type I quantitative, Type II qualitative) or acquired.
  • Acquired deficiencies are more prevalent and linked to various clinical conditions.
  • Understanding antithrombin's structure-function relationship is vital for diagnosing and managing deficiencies.

Conclusions:

  • Antithrombin plays a multifaceted role beyond anticoagulation, impacting inflammation, tumor growth, and viral defense.
  • Accurate detection methods are essential for identifying both inherited and acquired antithrombin deficiencies.
  • Further research into antithrombin's therapeutic potential is warranted.